Edge effects on the intrinsic magnetism in ferromagnetic triangular phosphorene quantum dots using fully spin-polarized calculations.

This project involves discovering the electronic and magnetic properties of nanometer-sized phosphorene structures with triangular shapes in both zigzag and armchair termination types. The goal is to discuss the relationship between the electronic states belonging to the different conditions of these phosphorene quantum dots and their intrinsic magnetic properties. For this purpose, we consider electronic interactions utilizing the spin-polarized density functional theory calculations, and then the results compare with the data generated from tight-binding calculations. Both descriptions yield mid-gap states in the spectrum of ferromagnetic structures. Our results in non-spin computations without any geometry optimization were matched by tight-binding calculations which shows that the tight-binding method is an inefficient approximation in analyzing the optimized spin samples. Unlike graphene, in our spin-polarized calculations, we have obtained empty mid-gap states in the spectrum of ferromagnetic triangular phosphorene quantum dots. The edge atoms of these structures are known as the magnetic atoms with an unequal contribution of spin up and spin down. To prevent deforming the initial structures, the dangling bonds at the edge atoms were passivated in two types, fully hydrogenated and partial passivation with oxygen atoms. Oxygen doping was required for introducing magnetism to the non-spin edges of the fully hydrogenated case.

Acute myeloid leukemia targets for bispecific antibodies.

Despite substantial gains in our understanding of the genomics of acute myelogenous leukemia (AML), patient survival remains unsatisfactory especially among the older age group. T cell-based therapy of lymphoblastic leukemia is rapidly advancing; however, its application in AML is still lagging behind. Bispecific antibodies can redirect polyclonal effector cells to engage chosen targets on leukemia blasts. When the effector cells are natural-killer cells, both antibody-dependent and antibody-independent mechanisms could be exploited. When the effectors are T cells, direct tumor cytotoxicity can be engaged followed by a potential vaccination effect. In this review, we summarize the AML-associated tumor targets and the bispecific antibodies that have been studied. The potentials and limitations of each of these systems will be discussed.

Inducible T-cell receptor expression in precursor T cells for leukemia control.

Co-transplantation of hematopoietic stem cells with those engineered to express leukemia-reactive T-cell receptors (TCRs) and differentiated ex vivo into precursor T cells (preTs) may reduce the risk of leukemia relapse. As expression of potentially self-(leukemia-) reactive TCRs will lead to negative selection or provoke autoimmunity upon thymic maturation, we investigated a novel concept whereby TCR expression set under the control of an inducible promoter would allow timely controlled TCR expression. After in vivo maturation and gene induction, preTs developed potent anti-leukemia effects. Engineered preTs provided protection even after repeated leukemia challenges by giving rise to effector and central memory cells. Importantly, adoptive transfer of TCR-transduced allogeneic preTs mediated anti-leukemia effect without evoking graft-versus-host disease (GVHD). Earlier transgene induction forced CD8(+) T-cell development was required to obtain a mature T-cell subset of targeted specificity, allowed engineered T cells to efficiently pass positive selection and abrogated the endogenous T-cell repertoire. Later induction favored CD4 differentiation and failed to produce a leukemia-reactive population emphasizing the dominant role of positive selection. Taken together, we provide new functional insights for the employment of TCR-engineered precursor cells as a controllable immunotherapeutic modality with significant anti-leukemia activity.